These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 29056150)

  • 21. The redox modulatory effects of SP/NK1R system: Implications for oxidative stress-associated disorders.
    Ebrahimi S; Alalikhan A; Aghaee-Bakhtiari SH; Hashemy SI
    Life Sci; 2022 May; 296():120448. PubMed ID: 35247438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of neurogenic substance P in overexpression of alveolar macrophages' neurokinin 1 receptor in mice exposed to cigarette smoke.
    Xu J; Xu F
    Exp Lung Res; 2010 May; 36(4):243-54. PubMed ID: 20426532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance P activates responses correlated with tumour growth in human glioma cell lines bearing tachykinin NK1 receptors.
    Palma C; Nardelli F; Manzini S; Maggi CA
    Br J Cancer; 1999 Jan; 79(2):236-43. PubMed ID: 9888463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular and behavioral effects of lipopolysaccharide treatment are dependent upon neurokinin-1 receptor activation.
    Fulenwider HD; Smith BM; Nichenko AS; Carpenter JM; Nennig SE; Cheng K; Rice KC; Schank JR
    J Neuroinflammation; 2018 Feb; 15(1):60. PubMed ID: 29486768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunolocalization of Substance P and NK-1 Receptor in ADIPOSE Stem Cells.
    Muñoz M; Muñoz MF; Ayala A
    J Cell Biochem; 2017 Dec; 118(12):4686-4696. PubMed ID: 28500728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV.
    Barrett JS; Spitsin S; Moorthy G; Barrett K; Baker K; Lackner A; Tulic F; Winters A; Evans DL; Douglas SD
    J Transl Med; 2016 May; 14(1):148. PubMed ID: 27230663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of substance P in the cardiovascular system.
    Mistrova E; Kruzliak P; Chottova Dvorakova M
    Neuropeptides; 2016 Aug; 58():41-51. PubMed ID: 26706184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A constitutively active form of neurokinin 1 receptor and neurokinin 1 receptor-mediated apoptosis in glioblastomas.
    Akazawa T; Kwatra SG; Goldsmith LE; Richardson MD; Cox EA; Sampson JH; Kwatra MM
    J Neurochem; 2009 May; 109(4):1079-86. PubMed ID: 19519779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of the neurokinin 1 receptor by TNFα in endometriotic tissue provides the potential for neurogenic control over endometriotic lesion growth.
    McKinnon BD; Evers J; Bersinger NA; Mueller MD
    J Clin Endocrinol Metab; 2013 Jun; 98(6):2469-77. PubMed ID: 23553861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor.
    Spitsin S; Tuluc F; Meshki J; Ping Lai J; Tustin Iii R; Douglas SD
    Neuroimmunomodulation; 2013; 20(5):247-55. PubMed ID: 23921645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normative distribution of substance P and its tachykinin neurokinin-1 receptor in the medullary serotonergic network of the human infant during postnatal development.
    Bright FM; Byard RW; Vink R; Paterson DS
    Brain Res Bull; 2018 Mar; 137():319-328. PubMed ID: 29331576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance P excites GABAergic neurons in the mouse central amygdala through neurokinin 1 receptor activation.
    Sosulina L; Strippel C; Romo-Parra H; Walter AL; Kanyshkova T; Sartori SB; Lange MD; Singewald N; Pape HC
    J Neurophysiol; 2015 Oct; 114(4):2500-8. PubMed ID: 26334021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.
    Garnier A; Vykoukal J; Hubertus J; Alt E; von Schweinitz D; Kappler R; Berger M; Ilmer M
    Int J Oncol; 2015 Jul; 47(1):151-60. PubMed ID: 25998227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of substance P in the marginal division of the neostriatum in learning and memory is mediated through the neurokinin 1 receptor in rats.
    Liu XM; Shu SY; Zeng CC; Cai YF; Zhang KH; Wang CX; Fang J
    Neurochem Res; 2011 Oct; 36(10):1896-902. PubMed ID: 21611833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Substance P, A Promising Therapeutic Target in Musculoskeletal Disorders.
    Ko KR; Lee H; Han SH; Ahn W; Kim DK; Kim IS; Jung BS; Lee S
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neurokinin-1 receptor mediates escalated alcohol intake induced by multiple drinking models.
    Sequeira MK; Nelson BS; Fulenwider HD; King CE; Nennig SE; Bohannon JB; Cheng K; Rice KC; Heilig M; Schank JR
    Neuropharmacology; 2018 Jul; 137():194-201. PubMed ID: 29758386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alcohol-induced conditioned place preference negatively correlates with anxiety-like behavior in adolescent mice: inhibition by a neurokinin-1 receptor antagonist.
    Huang H; Zhang X; Fu X; Zhang X; Lang B; Xiang X; Hao W
    Psychopharmacology (Berl); 2018 Oct; 235(10):2847-2857. PubMed ID: 30054674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of full-length and truncated neurokinin-1 receptors on tumor progression and distant metastasis in human breast cancer.
    Zhou Y; Zhao L; Xiong T; Chen X; Zhang Y; Yu M; Yang J; Yao Z
    Breast Cancer Res Treat; 2013 Jul; 140(1):49-61. PubMed ID: 23807418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tachykinin Receptor-Selectivity of the Potential Glioblastoma-Targeted Therapy, DOTA-[Thi
    Suthiram J; Pieters A; Mohamed Moosa Z; Zeevaart JR; Sathekge MM; Ebenhan T; Anderson RC; Newton CL
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurokinin 1 Receptor Antagonists for Pruritus.
    Alam M; Buddenkotte J; Ahmad F; Steinhoff M
    Drugs; 2021 Apr; 81(6):621-634. PubMed ID: 33675531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.